Advertisement

Topics

Genomic Assays Advance Personalized Care in Early-Stage Breast Cancer

12:01 EDT 16 Apr 2019 | OncLive

Mariana Chavez Mac Gregor, MD, MSc, discusses the optimal applications of these assays in patients with early-stage, HR-positive/HER2-negative breast cancer and shed light on the overall outlook of personalized medicine in this setting.

Original Article: Genomic Assays Advance Personalized Care in Early-Stage Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Genomic Assays Advance Personalized Care in Early-Stage Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...